SEARCH

SEARCH BY CITATION

References

  • 1
    Asherson RA, Cervera R: Anticardiolipin antibodies, chronic biologic false-positive tests for syphilis and other antiphospholipid antibodies. In, Dubois' Lupus Erythematosus. Fourth edition. Philadelphia, Lea and Febiger, 1993
  • 2
    Hughes GRV: The antiphospholipid antibody syndrome: 10 years on. Lancet 342: 341344, 1993
  • 3
    McNeil HP, Chesterman CN, Krilis SA: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49: 193280, 1990
  • 4
    Koike T, Sueishi M, Funaki H, Tomioka H, Yoshida S: Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 56: 193199, 1984
  • 5
    Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, Ferenc M: Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 313: 152156, 1985
  • 6
    Hamsten A, Norberg R, Bjorkholm M, de Faire V, Holm G: Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 1: 113116, 1986
  • 7
    Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV: Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch Intern Med 146: 21532156, 1986
  • 8
    Fort JG, Cowchock FS, Abruzzo JL, Smith JB: Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 30: 752760, 1987
  • 9
    Kalunian KC, Peter JB, Middlekauff HR, Sayre J, Ando DG, Mangotich M, Hahn BH: Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 85: 602608, 1988
  • 10
    Shergy WJ, Kredich DW, Pisetsky DS: The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 15: 13891394, 1988
  • 11
    Weidmann CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR: Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 15: 7579, 1988
  • 12
    Shimada K, Koike T, Ichikawa K, Tsutsumi A, Takabayashi K, Tomioka H, Yoshida S: IgG class anticardiolipin antibody as a possible marker for evaluating fetal risk in patients with systemic lupus erythematosus. J Autoimmun 2: 843849, 1989
  • 13
    Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Baguley E, Hughes GRV: Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 86: 391399, 1989
  • 14
    Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, Fernandez L, Ponce de Leon S: Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective study of 500 consecutive patients. Medicine (Baltimore) 68: 353365, 1989
  • 15
    Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Ann Intern Med 112: 682698, 1990
  • 16
    Castenon C, Amigo M, Banales JL, Nava A, Reyes PA: Ocular vasoocculusive disease in primary antiphospholipid syndrome. Ophthalmology 102: 256262, 1995
  • 17
    McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87: 41204124, 1990
  • 18
    Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda Vriesman PJ, Barbui T, Zwaal RF, Bavers EM: Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma cofactor. Lancet 335: 15441547, 1990
  • 19
    Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T: Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336: 177178, 1990
  • 20
    Koike T, Matsuura E: What is the “true” antigen for anticardiolipin antibodies? Lancet 337: 671672, 1991
  • 21
    Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T, Yasuda T, Koike T: Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 148: 38853891, 1992
  • 22
    Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T: Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179: 457462, 1994
  • 23
    Koike T, Tsutsumi A, Ichikawa K, Matsuura E: Antigenic specificity of the “anticardiolipin” antibodies (letter). Blood 85: 22772278, 1995
  • 24
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 12711277, 1982
  • 25
    Schleider MA, Nachman RL, Jaffe EA, Coleman M: A clinical study of the lupus anticoagulant. Blood 48: 499509, 1976
  • 26
    Roubey RA, Eisenberg RA, Harper MF, Winfield JB: “Anticardiolipin” autoantibodies recognize β2-glycoprotein I in the absence of phospholipid: importance of Ag density and bivalent binding. J Immunol 154: 954960, 1995
  • 27
    Oosting JD, Derksen RHWM, Bobbink IWG, Hackeng TM, Bouma BN, de Groot PG: Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 81: 26182625, 1993
  • 28
    Permpikul P, Rao LVM, Rapaport SI: Functional and binding studies of the roles of prothrombin and β2-glycoprotein I in the expression of lupus anticoagulant activity. Blood 83: 28782892, 1994
  • 29
    Farrugia E, Torres VE, Gastinaeu D, Michet CJ, Holley KE: Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kidney Dis 20: 463471, 1992
  • 30
    Green D, Hougie C, Kazmier FJ, Lechner K, Mannucci PM, Rizza CR, Sultan Y: Report of the working party on acquired inhibitors of coagulation: studies of the “lupus” anticoagulant. Thromb Haemost 49: 144146, 1983
  • 31
    Colaco CB, Elkon KB: The lupus anticoagulant: a disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA. Arthritis Rheum 28: 6774, 1985
  • 32
    Feinstein DI, Francis RB: The lupus anticoagulant. In, Dubois' Lupus Erythematosus. Fourth edition. Philadelphia, Lea and Febiger, 1993